4885.T
MUROMACHI CHEMICALS INC.
スタンダード · 医薬品 · 医薬品 · JP
JPY 904.00
+0.22%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.4B | 6.7B | 6.4B | 6.3B | 5.7B |
| Cost of Revenue | 1.3B | 4.7B | 4.5B | 4.5B | 3.9B |
| Gross Profit | 490.9M | 2.0B | 1.9B | 1.8B | 1.7B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 416.3M | 1.5B | 1.4B | 1.4B | 1.3B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 416.3M | 1.5B | 1.4B | 1.4B | 1.3B |
| Cost and Expenses | 6.7B | 6.2B | 5.9B | 5.9B | 5.2B |
| Operating Income (EBIT) | 627.0M | 432.0M | 421.0M | 369.0M | 437.0M |
| Non-Operating | |||||
| Interest Income | 2.1M | 2.3M | 2.1M | 38.0K | 4.0K |
| Interest Expense | 11.9M | 29.0M | 18.5M | 17.7M | 17.0M |
| Net Interest Income | (9.8M) | (26.7M) | (16.3M) | (17.7M) | (17.0M) |
| Other Non-Op Income/Expense | (1.7M) | (2.1M) | 6.3M | (18.5M) | (14.3M) |
| Non-Operating Income (excl Interest) | 8.3M | 27.8M | 24.1M | 12.8M | 10.4M |
| EBT (Pre-Tax Income) | 73.0M | 350.0M | 468.6M | 350.9M | 425.6M |
| Income Tax Expense | 15.5M | 108.8M | 138.4M | 94.6M | (30.7M) |
| Bottom Line | |||||
| Net Income | 365.0M | 241.0M | 330.0M | 256.0M | 456.0M |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 365.0M | 241.0M | 330.0M | 256.0M | 456.0M |
| Per Share | |||||
| Basic EPS | ¥91 | ¥60 | ¥83 | ¥68 | ¥124 |
| Diluted EPS | ¥91 | ¥59 | ¥82 | ¥64 | ¥113 |
| Revenue Per Share | ¥1,838 | ¥1,666 | ¥1,609 | ¥1,668 | ¥1,541 |
| Shares | |||||
| Basic Shares Outstanding | 4.0M | 4.0M | 4.0M | 3.8M | 3.7M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 593.7M | 557.2M | 491.3M | 538.2M |
| D&A | — | 161.7M | 136.2M | 122.3M | 101.2M |
| EBIT | 627.0M | 432.0M | 421.0M | 369.0M | 437.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Feb 1, 2026